BESTSELLER

Autoimmune Disease Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Autoimmune Disease Diagnostics Market is Segmented by Disease Type ( Systemic Autoimmune Disease​ and Localized Autoimmune Disease​), Diagnosis Type, and Geography

Market Snapshot

autoimmune disease diagnostics market
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 8.3 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The autoimmune disease diagnostics market is expected to register a CAGR of nearly 8.3% during the forecast period. The rising awareness about autoimmune diseases through programs of research, education, support, and advocacy is a key factor boosting the usage rates of autoimmune disease diagnostics, globally. The United States has the highest incidence of autoimmune diseases, wherein about 50 million patients suffer from autoimmune diseases. According to Arthritis Foundation, in 2017 about 54.4 million adults in the United States suffer from diagnosed arthritis. Furthermore, according to the 2017 report of the International Diabetes Federation (IDF), approximately 425 million adults (20-79 years) were suffering from diabetes, and by 2045 this number may rise to 629 million, globally.

Government organizations and NGOs aims to increase awareness about the socioeconomic impact of autoimmunity through fostering and facilitating collaboration in the areas of education, public awareness, research, and patient services in an effective, ethical, and efficient manner. The other factors, such as improved laboratory automation, partnerships with physicians and clinical laboratories, and technological advancements, are driving the autoimmune disease diagnostics market. However, the slow turnaround time of the diagnosis and high frequency of false results are hindering the growth of the autoimmune disease diagnostics market.

Scope of the Report

As per scope of the report, autoimmunity involves the loss of normal immune homeostasis, as the organism produces an abnormal response to its own tissue. Autoimmune diseases generally involve the presence of self-reactive T cells, autoantibodies, and inflammation. Diagnosis of potential autoimmune diseases is very difficult, because not one laboratory test alone can produce diagnosis results for the disease. The diagnosis can be useful in the management of patients suffering from autoimmune diseases and help in providing a prognosis or indicating the severity of organ involvement or damage. The autoimmune disease diagnostics market is segmented by by disease type, diagnosis, and geography.

Disease Type
Systemic Autoimmune Disease
Rheumatoid Arthritis
Psoriasis
Systemic Lupus Erythematosus (SLE)
Multiple Sclerosis
Other Systemic Autoimmune Diseases
Localized Autoimmune Disease
Inflammatory Bowel Disease
Type 1 Diabetes
Thyroid
Other Localized Autoimmune Diseases
By Diagnosis
Antinuclear Antibody Tests​
Autoantibody Tests​
Complete Blood Count (CBC)​
C-reactive Protein (CRP)​
Urinalysis​
Others tests
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East & Africa
GCC
South Africa
Rest of Middle-East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Rheumatoid Arthritis Segment is Expected to Hold a Major Market Share in the Autoimmune Disease Diagnostics Market

Rheumatoid arthritis (RA) is an autoimmune disease that mainly attacks the synovial tissues within the joints. The disease predominantly affects elderly patients. The aging population coupled with technological advancements in immunofluorescence and proteomics technologies will further enhance the rheumatoid arthritis diagnosis influencing the segment growth.

The rising prevalence of diseases such as rheumatoid arthritis, Hashimoto’s thyroiditis, and the presence of favorable government regulations will render a significant impact on the autoimmune disease diagnostics market growth. As per the American Autoimmune Related Diseases Association, around 50 million Americans currently suffer from autoimmune-related disorders. Moreover, the numbers are expected to escalate over the forecast period. The demand for better and precise diagnostic methods, along with the increasing prevalence, is expected to increase over the forecast period.

Auto immune key trend 1.png

Asia-Pacific is the Fastest Growing Region in the Autoimmune Disease Diagnostics Market

Asia-Pacific is anticipated to exhibit extensive market growth over the forecast period, owing to the presence of rising disposable income and increasing patient pool in emerging countries. Furthermore, growing awareness regarding the benefits of early and accurate diagnosis of autoimmune diseases to seek right treatment, rising development of healthcare infrastructure, and growing healthcare expenditure are likely to boost the growth of the autoimmune disease diagnostics market in the Asia-Pacific region.

Growth strategies adopted by the local and international players in the Asia-Pacific region is also propelling the growth of the autoimmune disease diagnostics market. In 2017, ImmunArray, a privately-held molecular device diagnostic company, and Kindstar Global Co. Ltd, a speciality clinical testing company based in Wuhan, forged a partnership to undertake joint clinical testing for lupus, due to the growing prevalence of the disease in China.

Autoimmune Disease Diagnostics Market2

Competitive Landscape

The Autoimmune Disease Diagnostics Market is fragmented competitive. The market comprises of major market players, and these players are focusing on R&D activities and significant growth strategies. Recently, a few diagnostic companies entered into strategic partnerships with hospitals. This trend is expected to continue over the next few years, in order to meet the high volume of patient needs, across different regions.

In July 2017, AARDA, in partnership with the Relapsing Polychondritis Awareness & Support Foundation (RPASF), hosted the first Bowling Green Autoimmune Walk and Warriors 5K Fun Run to raise awareness and funding for innovative research. In May 2017, Thermo Fisher Scientific acquired Patheon.

In June 2017, Bio-Rad signed an agreement with VISIA imaging for fully-automated IFA Slide Processing and Reading System. Thus, the market has been witnessing technological developments on a large scale for the past couple of years.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Burden of Autoimmune Diseases and Rising Public Awareness​

      2. 4.2.2 Technological Advancements and Improved Laboratory Automation​

    3. 4.3 Market Restraints

      1. 4.3.1 Slow Turnaround Time of Results and Need for Multiple Diagnostic Tests

      2. 4.3.2 High Cost and Reimbursement Issues Coupled with Regulatory Uncertainties

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 Disease Type

      1. 5.1.1 Systemic Autoimmune Disease

        1. 5.1.1.1 Rheumatoid Arthritis

        2. 5.1.1.2 Psoriasis

        3. 5.1.1.3 Systemic Lupus Erythematosus (SLE)

        4. 5.1.1.4 Multiple Sclerosis

        5. 5.1.1.5 Other Systemic Autoimmune Diseases

      2. 5.1.2 Localized Autoimmune Disease

        1. 5.1.2.1 Inflammatory Bowel Disease

        2. 5.1.2.2 Type 1 Diabetes

        3. 5.1.2.3 Thyroid

        4. 5.1.2.4 Other Localized Autoimmune Diseases

    2. 5.2 By Diagnosis

      1. 5.2.1 Antinuclear Antibody Tests​

      2. 5.2.2 Autoantibody Tests​

      3. 5.2.3 Complete Blood Count (CBC)​

      4. 5.2.4 C-reactive Protein (CRP)​

      5. 5.2.5 Urinalysis​

      6. 5.2.6 Others tests

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Biomerieux

      3. 6.1.3 Bio-rad Laboratories

      4. 6.1.4 Euroimmun AG

      5. 6.1.5 F. Hoffmann-la Roche

      6. 6.1.6 Inova Diagnostics Inc.

      7. 6.1.7 Myriad Genetics

      8. 6.1.8 Siemens Healthineers Inc.

      9. 6.1.9 Thermo Fisher Scientific

      10. 6.1.10 Trinity Biotech

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape Covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Autoimmune Disease Diagnostics Market market is studied from 2018 - 2026.

The Autoimmune Disease Diagnostics Market is growing at a CAGR of 8.3% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Biomérieux, Trinity Biotech, Bio-rad Laboratories, Thermo Fisher Scientific are the major companies operating in Autoimmune Disease Diagnostics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!